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Abstract 
 Mitogen-activated kinase phosophatase-1 (MKP-1) inhibits the activity of extracellular 
signaling regulated kinase (ERK-1/2) via dephosphorylation. ERK-1/2 has been shown to be 
important for membrane excitability that results in corticotropin releasing hormone (CRH) 
peptide secretion and has been shown to regulate CRH gene transcription. Glucocorticoid 
hormones produce negative feedback by suppressing both CRH secretion and CRH gene 
transcription, although the specific molecular mechanism is unknown. In some peripheral tissue 
cell types, glucocorticoids induce MKP-1 gene transcription; therefore, MKP-1 could be a target 
gene that contributes to some of glucocorticoid negative feedback actions. We examined whether 
acute stress (restraint) and tonic glucocorticoids affect MKP-1 gene transcription within the 
hypothalamic paraventricular nucleus (PVN) and anterior pituitary elements of the 
hypothalamic-pituitary-adrenal (HPA) axis and in select brain regions (prelimbic and infralimbic 
cortex) that provide neural input to the HPA-axis. Rats were exposed to no stress or 30 min 
restraint stress (RS) and were left either adrenal intact or were adrenalectomized, and MKP-1 
mRNA was then measured using in situ hybridization. We found that restraint induced MKP-1 
gene expression within all the brain regions examined (PVN, prelimbic cortex, and infralimbic 
cortex) and the pituitary. Adrenalectomy also induced MKP-1 gene expression within all the 
regions we examined except the prelimbic cortex. Lastly, we also found that adrenalectomy 
augmented stress-induced MKP-1 expression within the pituitary. These results indicate that 
MKP-1 gene transcription is upregulated by stress-induced activation of intracellular signal 
transduction pathways in the brain and pituitary. However, contrary to the previous findings in 
some peripheral tissues, tonic glucocorticoids suppress rather than induce stress-induced MKP-1 
gene expression within the PVN.  
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I. Background 
HPA axis response to stress 
The hypothalamic-pituitary-adrenal (HPA) axis consists of three anatomical components. 
The first component is the paraventricular nucleus (PVN), which is situated within the 
hypothalamus of the brain. During a psychological or physical stress response, parvocellular 
neurons within the PVN release corticotropin- releasing hormone (CRH) into portal vessels. 
CRH then stimulates specialized endocrine cells (corticotrophs) in the anterior pituitary gland to 
release adrenocorticotrophic hormone (ACTH). ACTH in turn stimulates the adrenal gland to 
synthesize and secrete glucocorticoids. Glucocorticoids then via a process referred to as negative 
feedback inhibit further production of CRH, ACTH, and thus more glucocorticoids (30).  
Clinical relevance of stress 
Although glucocorticoids can be beneficial in a short term response to stress, chronic 
exposure to glucocorticoids have negative effects on the body that can contribute to illness. 
Unrestrained psychological stress is associated with hypertension, atherosclerosis, insulin 
resistance, abdominal fat accumulation, and asthma (11, 13, 19, 32). Moreover, psychological 
stress especially affects psychological disorders like depression and post-traumatic stress 
syndrome (PTSD) by either exacerbating the disorder or directly causing it. When HPA axis 
activity becomes dysregulated, the adrenal gland has an abnormal glucocorticoid secretion 
pattern, which can then contribute to the pathology of a disease (3). For instance, too much 
cortisol secretion and impaired glucocorticoid negative feedback has been linked to depressive 
episodes (1, 23). In contrast, too little cortisol secretion and enhanced negative feedback is 
associated with PTSD (3). Since HPA axis dysregulation affects so many prevalent diseases, it is 
crucial to understand glucocorticoid negative feedback mechanisms. 
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Glucocorticoids inhibit HPA axis activity 
 
Glucocorticoids are a subclass of corticosteroid 
hormones that have important immunological and 
metabolic functions. Glucocorticoids suppress 
inflammation and contribute to the regulation of 
carbohydrate, protein, and fat metabolism. More 
importantly, glucocorticoids (cortisol in humans and 
corticosterone in rats) are involved in the physiological 
and physical response to stress (27). Corticosterone 
(CORT) binds to two closely related receptors, the 
mineralcorticoid receptor (MR) than the GR. CORT 
binds with higher affinityto MR than the glucocorticoid receptor (GR). As a result, GR is 
significantly bound only when circulating CORT concentrations greatly increase such as during 
an acute stress response (23, 24, 29). Both receptors are intracellular and act as hormone-
dependent transcription factors (Figure 1). When ligand is not present, GR resides in the cytosol 
and MR resides both in the cytosol and nucleus (2). Both form a multi-protein complex until 
binding of ligand causes GR and MR to dissociate from the complex (activated) and translocate 
to the nucleus (36). Activated GR and MR then assemble into homodimers or heterodimers and 
bind to a glucocorticoid response element near certain target genes and thus promote or inhibit 
gene transcription (6). In addition to directly altering gene transcription, GR and MR can 
associate with other transcription factors (e.g. fos or CREB) or transcription factor ligands (e.g. 
Figure 1: Glucocorticoids bind to GR, assemble into 
homodimers and translocate to the nucleus where they 
can activate gene transcription. 
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CREB binding protein) to regulate gene transcription (18). By modulating gene transcription, 
glucocorticoids can alter the pattern of gene expression within a parvocellular neuron or a 
corticotroph and thereby inhibit stress-induced HPA axis activity.  
Glucocorticoids can directly and/or indirectly mediate negative feedback effects of the 
HPA axis (Figure 2). When CORT reaches the PVN, it 
binds to the glucocorticoid receptor (GR) within 
parvocellular neurons and inhibits further production of 
CRH, ACTH, and, as a result, glucocorticoids. Likewise, 
glucocorticoids bind to GR and MR in corticotrophs within 
the anterior pituitary and inhibit ACTH secretion, thereby 
preventing glucocorticoid secretion from the adrenal 
glands (30). However, glucocorticoids can also act 
indirectly to affect HPA axis activity (Figure 2). For 
instance, glucocorticoids can act on the ventral 
hippocampus, a brain region involved in memory and 
learning, to affect HPA axis activity.  The ventral 
hippocampus sends projections to the bed nucleus of the 
stria terminalis (BNST), which then projects to the PVN, 
thereby allowing glucocorticoids to affect CRH secretion 
(30). Likewise, the medial prefrontal cortex (mPFC) can 
also facilitate negative feedback effects on stress-induced 
HPA axis activity via projections to the BNST (34).  
Figure 2: Corticosterone can act directly on CRH 
neurons or corticotrophs and indirectly on brain 
regions outside of the PVN to induce glucocorticoid 
negative feedback effects. 
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Several factors affect CRH secretion from the PVN and CORT can influence any one of 
these factors (Figure 3). Parvocellular neurons do not sense stress; instead bisynaptic projections 
from the medial prefrontal cortex or hippocampus, for example, release neurotransmitters that 
provide signals to CRH neurons that effectively activate these neurons in response to a stressful 
event. Binding of these neurotransmitters to their receptors then causes activation of intracellular 
signal transduction pathways. The immediate effect of intracellular signal transduction pathway 
activation is the exocytosis of CRH peptide from vesicles at the axon terminal. However, 
activation of signal transduction pathways can also induce transcription of the CRH gene to 
replenish depleted prepackaged CRH peptides at the axon terminal. Signal transduction pathway 
activity also leads to transcriptional activation of other genes, like mkp-1 or c-fos, which may 
mediate cellular adaption to chronic stress (33). CORT could produce negative feedback effects 
by altering activity of the neural input to the PVN or interfering with signal transduction 
pathways that thereby affects membrane excitability, neurohormone synthesis, and the cell’s 
pattern of gene expression.    
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Figure 3:  CRH secretion from CRH neurons can be affected by neurotransmitters, receptors, and 
second messenger pathways. Corticosterone negative feedback actions could target any one of these 
levels. Adapted from Watts (33).  
 
CORT also has permissive and 
reactive negative feedback effects on 
cellular function. During the day, a rat 
experiences a specific pattern of CORT 
secretion. In the morning, secreted CORT 
levels are very low until half way through 
the rat’s inactive period at which point 
CORT secretion begins to increase. CORT 
secretion peaks at the beginning of the active period and then begins declining back to basal 
Figure 4: CORT secretion pattern throughout the day for rats. 
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levels (Figure 4). This pattern of secretion represents tonic basal CORT secretion. The tonic 
presence of CORT has “permissive” actions on cellular function, especially within the PVN or 
pituitary (26). When tonic CORT is removed by adrenalectomy, basal and stimulated activity of 
CRH neurons and corticotrophs is upregulated (3). On the other hand, acute stress causes a short-
lived, phasic increase in CORT secretion (Figure 4). Phasic CORT has many “reactive” effects 
on various physiological systems that protect the body from the acute effects of stressors (20). 
However, the scope to which reactive effects function through different mechanisms from 
permissive effects of CORT remains unclear.  
ERK-1/2 may be a mediator of glucocorticoid negative feedback effects 
 Extracellular signal regulated kinase 1/2 (ERK-1/2) is an intracellular signaling molecule 
that may play a role in glucocorticoid negative feedback effects. Once ERK-1/2 is 
phosphorylated (pERK) on a threonine and tyrosine residue, it becomes active and can then 
phosphorylate other proteins within the cell. For instance, pERK directly activates transcription 
factors like c-fos (11). pERK also indirectly activates the transcription factor cAMP response 
element binding protein  (CREB) (10), which is the primary transcription factor for the crh gene 
(35). Thus, pERK could be a mediator for stress-induced crh gene expression within the PVN. In 
addition, pERK also helps maintain neuronal excitability and therefore could contribute to the 
membrane excitability that causes exocytosis of CRH (7, 9). Therefore, if tonic or phasic CORT 
can alter pERK activity within CRH neurons, then corticosterone could directly modify CRH 
neuron function.  
 Our lab has shown that restraint stress, a psychological stressor, increases pERK in the 
PVN within five minutes. We also find, using a double labeled immunohistochemistry 
procedure, that much of the stress-induced pERK within the PVN is colocalized within CRH 
10 
 
neurons (Figure 5). These results are important because they indicate that pERK is an 
intracellular signaling molecule that is activated within CRH neurons in response to stress-
induced changes in neurotransmitter input to those neurons. Therefore, regulation of pERK 
levels within CRH neurons could be a direct or indirect target for CORT negative feedback 
actions. In support of that prospect, the removal of tonic CORT by adrenalectomy augments 
stimulated levels of pERK within the PVN (Figure 6). Adrenalectomy also causes increases 
plasma ACTH levels in basal and stimulated states. However, when adrenalectomized rats are 
given corticosterone replacement in their drinking water, pERK and ACTH levels are normalized 
back to levels of adrenal intact (Sham) rats (Figure 7). Therefore, CORT, rather than other 
hormones secreted by the adrenal gland, tonically constrains stress-induced pERK levels within 
the PVN.  
 
Figure 5: Restraint stress induces pERK within CRH neurons. 
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Figure 6: 15min RS induces pERK within the PVN. 
Adrenalectomy (ADX) augments stress-induced pERK. 
An asterisk indicates that group is significantly different 
from its pairwise no stress group while a pound sign  
indicates that a group is significantly different from its 
pairwise ADX group. 
 
Figure 7: CORT replacement normalizes pERK back to sham 
levels within the PVN. An asterisk indicates that group is 
significantly different from its pairwise no stress group while a 
pound sign indicates that a group is significantly different from 
its pairwise ADX group. A plus sign indicates that the stress 
ADX and CORT replacement group is significantly different 
from its pairwise no stress group.  
 
MKP-1 regulates ERK-1/2 activity 
 Mitogen-activated kinase phosphatase 1 (MKP-1) is part of a larger family of 
phosphatases that dephosphorylate MAP kinases. In particular, MKP-1 regulates ERK-1/2 
activity. Once a mitogen-activated protein kinase kinase (e.g. MEK) adds a phosphate group to a 
tyrosine and threonine residue on ERK (pERK), MKP-1 can bind to pERK. MKP-1 contains a 
MAP kinase docking site at its amino terminus that has a cluster of positively charged amino 
acids which interact with negatively charged amino acids on pERK. Binding of pERK then 
causes a conformational change in MKP-1 that allows it to remove the phosphate groups on 
pERK, thereby rendering it inactive. The two proteins then lose affinity for each other and 
separate (31).  
Since pERK activity contributes to membrane excitability and neurohormone gene 
induction, MKP-1 could be an important target of glucocorticoid negative feedback actions. 
Moreover, glucocorticoids were shown to inhibit pERK by upregulating mkp-1 expression and 
decreasing MKP-1 degradation in fibroblast cells (17). Likewise, glucocorticoids were also 
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shown to induce MKP-1 gene expression and dephosphorylate pERK in osteoblast cells (6). 
Although MKP-1 activity and expression has not been previously characterized within CRH 
neurons, the previous results in other cell types suggests that CORT could upregulate MKP-1 
gene expression and thereby reduce the levels and/or duration of ERK activation. Therefore, 
MKP-1 upregulation could limit ERKs ability to contribute to CRH release and production of 
new neurohormone peptide.  
Preliminary Studies 
I have assisted with several preliminary studies in the Spencer Lab exploring the 
feasibility of studying MKP-1 mRNA expression in rat brain. Outlined below are the key 
findings of those preliminary studies that set the stage for this Honors Thesis project.  
Preliminary Experiment 1 
 Since glucocorticoids were shown to induce MKP-1 gene expression in other cell types 
such as osteoblast cells, we believed that glucocorticoids may also induce MKP-1 gene 
expression within neurons. As a result, we examined whether phasic CORT could affect MKP-1 
gene transcription. Also, we wanted to characterize MKP-1 gene transcription within the 
prefrontal cortex (PFC) in response to CORT pretreatment because the PFC had been shown to 
indirectly modulate HPA axis activity. 
 Rats received either a CORT or vehicle pretreatment 1 or 3 hours prior to decapitation. 
We found that there was very little constitutive expression of the MKP-1 gene within the PVN 
and that phasic CORT had no effect on MKP-1 gene expression (Figure 8). However, we did 
find constitutive MKP-1 gene expression within the prelimbic and cingulate regions of the PFC. 
Interestingly, rats that received a 1 hour pretreatment, regardless of whether the pretreatment was 
the vehicle or CORT solution, showed markedly higher amounts of MKP-1 mRNA in the 
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prefrontal cortex. This suggested that the stress associated with the handling of these rats 
increased MKP-1 gene expression and that by 3 hours MKP-1 gene expression was returning to 
basal levels.  
Preliminary Experiment 2 
We then examined the effect of restraint stress on MKP-1 gene expression. Given that 
restraint increased pERK activity within CRH neurons, we believed that MKP-1 gene expression 
also had the potential to be altered by stress because other studies have found increased MKP-1 
gene induction as a result of increased MAPK pathway activity (16). MKP-1 gene induction 
could be an effective a mechanism to limit the extent to which a cell is exposed to the effects of 
continued activation of MAP kinases (ERK).  
 We gave rats no stress (NS), 15 min, or 30 min restraint stress (RS) and measured MKP-1 
gene expression within the PVN. We found that restraint induced MKP-1 mRNA compared to 
the NS group, with the highest amount of MKP-1 mRNA in rats that received 30 min restraint 
(Figure 9).  
The result of this second preliminary experiment indicated that intracellular signaling 
pathways activated by stress-induced input to parvocellular neurons caused induction of MKP-1 
gene transcription. Since MKP-1 inhibits pERK activity and pERK contributes to CRH peptide 
release and synthesis, we believed that our finding provided support for the idea that MKP-1 
could be a target for glucocorticoid negative feedback actions. As a result, we decided to further 
examine MKP-1 gene expression in response to restraint stress in this Honors Thesis project. 
Moreover, although in the first preliminary experiment we found that phasic CORT did not 
affect basal MKP-1 gene expression within the PVN or PFC, we did not want to rule out the 
possibility that CORT could influence MKP-1 gene transcription. One possibility is that CORT 
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is not able to induce MKP-1 gene expression in the brain, but that CORT modulates stress-
induced gene expression. Another consideration is that as previously mentioned, the extent to 
which phasic and tonic CORT causes negative feedback effects through different mechanisms 
has not been characterized. Thus, although phasic CORT did not affect MKP-1 gene 
transcription, tonic CORT could alter its expression. As a result, in this Honors Thesis project, 
we decided to look at the effects of tonic CORT on basal and stress-induced MKP-1 gene 
expression by removing endogenous glucocorticoids through adrenalectomy.  
We believed that the results of this Honors Thesis project would be consistent with the 
results from the second preliminary experiment in that restraint stress would induce MKP-1 gene 
expression. Based on the results found in peripheral cell types, we believed that glucocorticoids 
would induce MKP-1 gene expression. The upregulation of the MKP-1 gene, we believed, would 
then limit pERK activity, which would decrease CRH peptide release and CRH gene 
transcription and thus contribute to glucocorticoid negative feedback effects.  
 
Figure 8: Phasic CORT pretreatment has no effect on MKP-1 gene expression within the PVN or PFC 
(prelimbic and cingulate cortex). Note the substantially larger MKP-1 mRNA amounts within the PFC  
of rats that received a 1 hour vehicle or CORT pretreatment compared to the 3 hour pretreatment.  
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Figure 9: Restraint stress induces MKP-1 mRNA within the PVN, with the 
highest levels at 30min RS. The asterisk indicates groups that are 
significantly different from the no stress (NS) group. 
 
 
 
II. Methods 
Animals 
 Young adult male Sprague-Dawley rats (Harlan Laboratories, Indianapolis, IA) weighing 
between 280 and 305 g at time of experimentation were housed two per-cage. The colony room 
lights were regulated on a 12 hour light/dark cycle and rats were given rat chow (Purina Rat 
Chow, Ralston Purina, St. Louis, MO, USA) and tap water ad libitum. Rats were allowed at least 
a 2 week acclimation to the colony room before any initiation of experimental procedures. The 
experiment was performed during the first half of the rats’ inactive period, when basal CORT 
secretion is at its circadian trough. Handling and testing of all rats conformed to ethical 
procedures approved by the University of Colorado Institutional Animal Care and Use 
Committee. 
Surgery 
 Rats were adrenalectomized bilaterally (ADX) or were sham-ADX. After being 
anesthetized with halothane, rats received bilateral incisions made through the skin and 
peritoneal wall next to each kidney. Sham-ADX rats experienced the same procedure as ADX 
* 
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rats, but adrenal glands were not removed. Moreover, all ADX and sham-ADX rats were given 3 
days to recover from surgery before the experimental test day. ADX rats were given 0.9% saline 
drinking water ad libitum. 
Experimental Design 
On experiment day, ADX and Sham-ADX rats received either no stress or 30min 
restraint stress before decapitation (2x2 between subjects factorial design; n=6; N=24). Plexiglas 
restraint tubes that measured 17.5 cm in length and 7.0 cm in diameter were used. The front end 
of the tube was blocked by a Plexiglas plunger containing several air holes. Immediately after 
decapitation, brains were removed and placed in isopentane (between -30 and -40 C) to flash 
freeze, after which brains were placed in a -80 C freezer for later analysis. Blood samples were 
centrifuged, and plasma was removed and stored at -80 C until later analysis. Directly after 
decapitation, trunk blood was collected into EDTA coated tubes (vacutainer, Becton-Dickinson). 
All samples were centrifuged for 15 min at 4 C to separate plasma from the red blood cells, 
plasma samples were then aliquoted into microfuge tubes and snap frozen on dry ice.  
ACTH radioimmunoassay 
ACTH (pg/ml) was determined in duplicate (100 µl plasma) by competitive 
radioimmunoassay protocol as described previously (21, 22). Radio-labeled 125I ACTH-Tracer 
was obtained from DiaSorin (Cat # 20515) and primary ACTH anti-serum Rb 7 diluted to a final 
concentration of 1:30,000 was provided courtesy of Dr. William Engeland, University of 
Minnesota.  
In Situ Hydridization (ISH) 
Brains were later sectioned in coronal slices at 12 µm thick (-20 C) on a cyrostat. Brain 
sections were thaw-mounted on Superfrost Plus slides. Slides were placed back in -80 C freezer 
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for later use on ISH assays. Sections used in ISH analysis were fixed in a buffered 4% 
paraformaldehyde solution for 30min at room temperature. Slides were washed in 2x saline 
sodium citrate (SSC) and acetylated in 0.1 M triethanolamine containing 0.25% acetic anhydride 
for 10 min to minimize nonspecific hydridization by reducing positive charge on tissue and 
Superfrost Plus slides. Slides were then washed again in SSC and then in distilled water, 
dehydrated in a series of graded ethyl alcohol concentrations, and air-dried. 
 35S-UTP labeled cRNA probes were generated for MKP-1 mRNA from cDNA 
subclones in transcription vectors using standard in vitro transcription methodology. Riboprobes 
were diluted in hydridization buffer to a concentration of approximately 1 million counts per 
slide (65 µl/slide). Diluted probe was applied, and a covership was placed on each slide. Slides 
were placed in sealed plastic boxes lined with chromatography paper moistened with 50% 
formamide in MQH2O and were incubated overnight at 55 C.  
 The next day, coverslips were floated off, and slides were rinsed several times in 2xSSC. 
The slides were then incubated in RNAse at 37 C for 1 hour to remove unhybridized RNA 
fragments. Slides were then washed successively in decreasing concentrations of SSC, incubated 
in a stringent wash of 0.1x SSC at 60 C for 1 hour to denature weakly bound hydrids, and then 
dehydrated in graded concentration of EtOH. Once the slides were dry, they were exposed to 
Kodak XAR X-ray film (Kodak, Rochester, NY, USA). Slides assayed for MKP-1 mRNA in the 
PVN had an exposure time of 17 days whereas pituitary sections were exposed to film for 14 
days. 
 Films were developed using a Kodak film developer. The amount of probe hydridized in 
each brain region were measured as regional optical densities of auto-radiographic film images 
18 
 
with a computerized image analysis system composed of a light box, a solid state video camera, 
and PC based NIH-image analysis software. 
 Uncalibrated optical densities for each region of interest, which included the PVN, 
anterior pituitary, prelimbic cortex, and infralimbic cortex, were measured using the program 
ImageJ.  For the PVN, measurements for four sections were taken for both hemispheres of the 
brain for all rats (8 measurements for each rat brain). Measurements were also taken for four 
sections of the anterior pituitary. On the other hand, both hemispheres of six sections were 
measured for the prelimbic and infralimbic cortex. Graphs showing relative differences between 
groups were created by measuring the average optical density for each rat and then averaging the 
optical densities of each rat to give an overall mean value for that treatment effect.  
Statistical Analysis 
For measurement of ACTH secretion, all absolute values for ACTH were normalized to 
be expressed as a proportion response to the no-stress SHAM group and then underwent log 
transformation for statistical purposes. A two-way factorial analysis of variance (ANOVA) was 
calculated in Statistical Package for the Social Sciences (SPSS) for each dependent measure. 
Significant F-test results were then followed with post hoc tests using Fishers Least Significant 
Difference Test (FLSD) in order to assess significant differences between pairs of groups. An 
alpha-level of P≤0.05 was used to determine statistical significance. For the graphs, an asterisk 
symbol over a particular group indicates that that group is significantly different from its pair 
wise no stress group. On the other hand, groups that are significantly different from their pair 
wise sham group are marked with a pound sign. 
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III. Results 
Rats challenged with 15 min of restraint increased ACTH secretion as supported by a 
main effect of stress F(1,19)=78.3, p<0.05 (Figure 10). The absence of glucocorticoid activity 
(via ADX) also increased ACTH secretion in both the no stress and restraint stress groups, as 
supported by a main effect of ADX F(1,19)=33.8, p<0.05.  
 
Figure 10: RS and ADX increase ACTH secretion. ADX  
augments stress-induced ACTH secretion. 
  
Rats exposed to restraint (30min) had an increase in MKP-1 gene expression in the PVN 
compared to the no stress groups F(1,19)=37.4, p<0.05 (Figure 11). Interestingly, ADX 
increased MKP-1 gene expression within the restraint stress group as supported by a main effect 
of ADX F(1,19)=11.0, p<0.05.   There was a trend for adrenalectomy to have exacerbated MKP-
1 gene expression within the restraint stress group, but this interaction between stress and 
adrenalectomy was not significant F(1,19)=2.21, p=0.154. 
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Figure 11: RS induces MKP-1 expression within the PVN compared to 
the NS group. ADX also increases MKP-1 expression compared to the  
Sham group.  
 
 For the anterior pituitary, there is a main effect of stress whereby restraint stress 
increased MKP-1 mRNA compared to the no stress groups F(1,19)=29.8, p<0.05 (Figure 12).  
Non-stressed Sham and ADX rats had the same amount of MKP-1 mRNA within the pituitary 
gland FLSD, p=0.89.However, loss of glucocorticoid activity via ADX augments MKP-1 gene 
expression of rats that were challenged with restraint F(1,19)=5.07, p<0.05 and consequently 
there is an interaction between restraint stress and ADX F(1,19)=5.1, p<0.05. 
 
Figure 12: RS induces MKP-1 mRNA within the pituitary. There is no  
effect of ADX within the NS group, however ADX augments stress-induced  
MKP-1 gene expression.  
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Restraint stress increased MKP-1 mRNA in both Sham and ADX rats compared to the no 
stress groups within the prelimbic cortex F(1,19)=14.7, p<0.05 (Figure 13). We found a trend for 
ADX to increase MKP-1 expression in both the no stress and restraint stress groups F(1,19)=3.12, 
p=0.09.  
 
Figure 13: RS induces MKP-1 mRNA within the prelimbic  
cortex, but there is no effect of ADX. 
 
Restraint induced MKP-1 gene expression in the infralimbic cortex F(1,19)=42.8, p<0.05 
(Figure 14). However, the loss of tonic glucocorticoid activity increased MKP-1 gene expression 
within both the no stress and restraint stress groups F(1,19)=7.9, p<0.05. 
 
Figure 14: Within the infralimbic cortex, RS and ADX induce  
MKP-1 gene expression. 
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 IV. Discussion 
 In this study we found that restraint stress induced HPA axis activity and ADX 
exacerbated stress-induced HPA axis activity as measured by ACTH hormone secretion. These 
results confirm previous findings (8, 22). Within all brain regions we examined and the anterior 
pituitary, restraint stress induced MKP-1 gene expression. Moreover, ADX augmented MKP-1 
gene expression in all regions except the prelimbic cortex. Interestingly, there was a significant 
interaction between stress and ADX within the pituitary. These findings suggest that restraint 
stress caused the activation of intracellular signaling transduction pathways that led to induction 
of MKP-1 gene expression and that tonic glucocorticoids suppressed stress-induced MKP-1 gene 
expression within the PVN and anterior pituitary.  
 The amount of ACTH secretion is indicative of HPA axis activity because activation of 
the HPA axis causes release of ACTH. Rats that received restraint stress showed elevated 
concentrations of ACTH within their circulation because the stress challenge caused HPA axis 
activation. Moreover, removal of the presence of glucocorticoids via ADX prevents tonic and 
phasic glucocorticoid negative feedback from happening, thus the HPA axis has increased 
continuous activation. When ADX was combined with restraint stress, ACTH secretion was 
exacerbated because the stress challenge caused activation of an already stimulated HPA axis. 
 We found that restraint stress induced MKP-1 expression within the PVN, pituitary, 
prelimbic cortex, and infralimbic cortex. Similarly, MKP-1 gene expression was induced within 
the prefrontal cortex upon receiving acute or chronic electroconvulsive seizures (15). Although 
we use restraint stress for our experimental design, the shock used to induce electroconvulsive 
seizures is a physical stressor. Therefore, it appears that stress causes the activation of 
intracellular signaling transduction pathways within prefrontal cortex neurons that lead to the 
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induction of MKP-1 gene expression. However, we are the first to examine MKP-1 gene 
expression in response to restraint stress within the PVN or pituitary.   
 Removal of endogenous glucocorticoids via ADX also induces MKP-1 gene expression 
within the PVN, pituitary, and the infralimbic cortex. MKP-1 mRNA within the prelimbic cortex 
was unaffected by ADX, however the prelimbic cortex has different cell populations than the 
other brain regions and pituitary. Therefore, prelimbic cortex neurons could respond differently 
to tonic glucocorticoids. Yet, we did find a strong trend for ADX to increase MKP-1 gene 
expression within the prelimbic cortex, so perhaps if we increased our sample size we would find 
a significant difference between ADX and Sham groups. Moreover, the magnitude of the effect 
of ADX on MKP-1 gene transcription is much larger within the PVN, which suggests that the 
PVN is more responsive to glucocorticoid negative feedback compared to the prelimbic and 
infralimbic cortex. The PVN has more GR than the frontal cortex (23), so this could explain why 
restraint stress has a larger effect within the PVN. Within cells where MKP-1 gene transcription 
was affected by ADX, tonic glucocorticoids could affect the transcription of genes besides MKP-
1 whose protein products then affect MKP-1 expression. However, it has recently been found 
that the MKP-1 gene has a glucocorticoid response element (GRE) (28). Although the previous 
study showed that glucocorticoids induced MKP-1 expression, it is possible that within neurons 
there are proteins that are not present within peripheral tissues at the GRE that interact with the 
GR to repress transcription of the MKP-1 gene.  
 ADX augments stress-induced MKP-1 gene expression within the pituitary. 
Corticotrophs that release ACTH differ from neurons in their function and pattern of gene 
expression. As a result, intracellular signaling pathways that are activated by stress have different 
outcomes within corticotrophs compared to the neuronal cell types we looked at. One outcome of 
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activation of intracellular signaling pathways within the pituitary appears to be the modulation of 
proteins that are targets of glucocorticoid actions as seen by the interaction between restraint 
stress and ADX.  
 Initially, we did not expect that tonic glucocorticoids would constrain MKP-1 gene 
transcription. Several studies within peripheral tissues indicated that glucocorticoids mediated 
anti-inflammatory effects by inhibiting ERK-1/2 via increased MKP-1 gene expression (5, 14), 
as well as decreased MKP-1 degradation (5). As a result, we believed that MKP-1 gene 
transcription would be upregulated by tonic CORT in order to prevent the responsiveness of 
signaling pathways to activation by stress-induced input. Yet, tonic CORT may indirectly repress 
MKP-1 gene expression by decreasing pERK activity. Our lab has shown that tonic CORT 
decreases pERK levels within the PVN, so it is possible that the decreased pERK activity could 
lead to less MKP-1 gene expression since MAPK pathway activity can regulate phosphatase 
gene expression (16). However, MKP-1 gene upregulation could help compensate for the 
inability to achieve glucocorticoid negative feedback in ADX rats because increased MKP-1 
gene expression probably leads to decreased pERK activity. This decreased pERK activity would 
result in decreased CRH peptide release and CRH gene transcription. Moreover, other research 
from our lab shows that ADX also induces numerous genes besides MKP-1 within the PVN and 
other various brain regions (8, 22). Therefore, it appears that tonic CORT constrains the overall 
activity of neurons and corticotrophs. When this constraint is taken away by ADX, gene 
expression of MKP-1, as well as other genes, is upregulated. Furthermore, tonic CORT could 
achieve this constraint by either altering the neural drive to PVN or acting directly within CRH 
neurons and corticotrophs. Also, our finding that tonic CORT, but not phasic CORT, represses 
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MKP-1 gene expression suggests that tonic and phasic CORT can use different mechanisms to 
affect gene transcription.  
 In the future, we need to confirm that tonic glucocorticoids, rather than other hormones 
secreted by the adrenal gland, suppress MKP-1 gene transcription. The increase in MKP-1 gene 
expression seen with ADX could be the result of other hormones secreted from the adrenal 
glands, or even the result of phasic CORT because removing the adrenal glands also takes away 
phasic CORT secretion. As a result, we should perform the same experiment, except add an 
additional treatment group that receives CORT in their drinking water to simulate a tonic CORT 
secretion pattern. If CORT replacement normalizes MKP-1 gene expression to Sham levels, then 
we can be certain that tonic CORT suppresses MKP-1 gene expression. Moreover, we should 
determine whether MKP-1 protein levels also change with restraint stress and ADX by repeating 
the same experiment and using immunohistochemistry or Western blot to examine MKP-1 
protein levels. It is possible that the amount of MKP-1 protein may not increase upon exposure 
to restraint stress or ADX because of mRNA degradation, so we need to rule this out. We should 
also try to determine whether tonic glucocorticoids suppress MKP-1 gene expression directly 
within the HPA axis or indirectly. To do this, we could surgically place a cannula above the PVN 
and give a microfusion of CORT to ADX rats that simulates a tonic glucocorticoid secretion 
pattern. If we obtain the same results whereby ADX increases MKP-1 gene expression and 
CORT normalizes MKP-1 mRNA to sham levels, then tonic glucocorticoids act directly within 
the PVN to suppress MKP-1 gene expression. Also, we could see if phasic CORT, when 
combined with restraint stress, alters MKP-1 gene expression. Since stress-induced input to the 
PVN and pituitary leads to the activation of signaling pathways that then alter gene transcription, 
it is possible that certain protein products of these genes may need to be present (or absent) in 
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order for phasic glucocorticoids to affect MKP-1 gene transcription.  More importantly, we need 
to determine whether pERK or tonic CORT is modulating MKP-1 gene expression by surgically 
placing a cannula above the PVN and microinfusing a MAPK pathway inhibitor. If we obtain the 
same results, then tonic CORT, rather than pERK, suppresses MKP-1 gene expression.  
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